Friday, 15 września |
07:30
– 08:30
|
Breakfast with an expert - strokes
Moderator
prof. dr hab. n. med. Agnieszka Słowik |
07:30
– 07:50
|
Small vessel disease
Wykładowca
prof. dr hab. n. med. Agnieszka Słowik |
07:50
– 08:10
|
Stroke caused by large-artery atherosclerosis
Wykładowca
|
08:10
– 08:30
|
Hemorrhagic stroke-can it be treated effectively?
|
08:30
– 09:30
|
Neurological emergencies
|
08:30
– 08:50
|
Intensive neurological care in status epilepticus and other paroxysmal disorders of consciousness
Wykładowca
|
08:50
– 09:10
|
Therapeutic implications of multifactorial monitoring of patients with acute stroke
Wykładowca
|
09:10
– 09:30
|
Life-threatening conditions in neuromuscular diseases
Wykładowca
dr n. med. Andrzej Opuchlik |
07:30
– 08:30
|
Breakfast with an expert - onconeurology
|
07:30
– 07:50
|
Neuropathology of paraneoplastic neurological syndromes
Wykładowca
|
07:50
– 08:10
|
Immunopathology of paraneoplastic neurological syndromes and interpretation of laboratory findings
Wykładowca
|
08:10
– 08:30
|
Management of patients eligible for radiotherapy for brain tumors
Wykładowca
dr n. med. Agnieszka Lewandowska |
08:30
– 09:30
|
Neuroinfections
"Complications of immunosuppressive therapies" Moderator
prof. dr hab. n. med. Mariusz Stasiołek |
08:30
– 08:50
|
Neuroinfections in MS patients treated with immunosuppressive therapy
Wykładowca
prof. dr hab. n. med. Mariusz Stasiołek |
08:50
– 09:10
|
Progressive multifocal leukoencephalopathy - current state of knowledge
Wykładowca
|
09:10
– 09:30
|
Neuroinfections in rheumatology patients treated with immunosuppressive therapy
|
07:30
– 08:30
|
Breakfast with an expert - neurorehabilitation
"New technologies in neurorehabilitation". |
07:30
– 07:50
|
Neuromodulation in neurorehabilitation - what does research say?
Wykładowca
|
07:50
– 08:10
|
Virtual reality in neurorehabilitation - treatment or fun?
Wykładowca
|
08:10
– 08:30
|
Telerehabilitation in neurological disorders - from the virtual world to 21st century reality
|
08:30
– 09:30
|
Neuropharmacology
|
08:30
– 08:50
|
Neuroprotection in neurology - what have we learned from preclinical studies on stroke models
Wykładowca
|
08:50
– 09:10
|
Generics and biosimilars in neurology
Wykładowca
dr hab. n. med. Janusz Szyndler |
09:10
– 09:30
|
Genetics and precision medicine in neuropharmacology today
|
Friday, 15 września |
09:30
– 09:45
|
Coffee break
|
Friday, 15 września |
09:45
– 11:15
|
Headaches
Moderator
|
09:45
– 10:05
|
Diagnosis and differentiation of trigeminal autonomic headaches
Wykładowca
|
10:05
– 10:25
|
Cardiovascular issues in migraine patients - own research
Wykładowca
prof. dr hab. n. med. Izabela Domitrz |
10:25
– 10:45
|
Pathogenesis of migraine based on own research
Wykładowca
|
10:45
– 11:05
|
Contemporary migraine management - own experience
|
11:05
– 11:15
|
Discussion
|
09:45
– 11:15
|
Strokes
Moderator
prof. dr hab. n. med. Agnieszka Słowik |
09:45
– 10:05
|
New developments in stroke diagnostics
|
10:05
– 10:25
|
Thrombolysis and thrombectomy- current status and future prospects
Wykładowca
prof. dr hab. n. med. Agnieszka Słowik |
10:25
– 10:45
|
Advances in stroke prevention
Wykładowca
|
10:45
– 11:05
|
Clinical trials in stroke - the future to come
Wykładowca
|
11:05
– 11:15
|
Discussion
|
09:45
– 11:15
|
Dementias
|
09:45
– 10:05
|
Vascular cognitive impairements - evolving criteria vs. treatment options
Wykładowca
prof. dr hab. n. med. Andrzej Szczudlik |
10:05
– 10:25
|
Diagnosis of dementia
Wykładowca
|
10:25
– 10:45
|
Evolution of dementia treatment
Wykładowca
|
10:45
– 11:05
|
The role of a psychiatrist in the diagnosis and treatment of dementia
Wykładowca
|
11:05
– 11:15
|
Discussion
|
Friday, 15 września |
11:15
– 11:30
|
Coffee break
|
Friday, 15 września |
11:30
– 13:30
|
Sponsored session
|
11:30
– 13:30
|
Sponsored session
|
11:30
– 13:30
|
Sponsored session
|
Saturday, 16 września |
07:30
– 08:30
|
Breakfast with an expert - Sleep Disorders
Moderator
|
07:30
– 07:50
|
Sleep disorders as a biomarker of neurological diseases
Wykładowca
prof. dr hab. n. med. Monika Rudzińska-Bar |
07:50
– 08:10
|
Narcolepsy
Wykładowca
|
08:10
– 08:30
|
Restless Legs Syndrome
Wykładowca
|
09:00
– 10:00
|
Video case session
Moderator
prof. dr hab. n. med. Dariusz Koziorowski |
09:00
– 09:15
|
Wilson's disease - early diagnosis, good results
|
09:15
– 09:30
|
Levodopa-sensitive dystonia
Wykładowcy
dr n. med. Marta Zawadzka |
09:30
– 09:45
|
Perry syndrome - atypical parkinsonism with hypoventilation and weight loss
|
09:45
– 10:00
|
Genetic movement disorders - advances in pathogenesis and treatment
Wykładowca
prof. dr hab. n. med. Dariusz Koziorowski |
10:00
– 10:15
|
Coffee break
|
10:15
– 12:00
|
Main partners session
|
12:00
– 12:20
|
Coffee break
|
12:20
– 13:45
|
Presidential session
|
12:20
– 12:40
|
Neuromodulation in Epilepsy
Wykładowca
prof. Paul Boon |
12:40
– 13:00
|
The evolving understanding of progressive MS
Wykładowca
|
13:00
– 13:20
|
Therapy development in neurology
Wykładowca
|
13:20
– 13:35
|
SARS-CoV-2 and the nervous system
Wykładowca
|
13:35
– 13:45
|
Professional burnout of Polish neurologists - results of a survey
|
13:45
– 14:50
|
Lunch break
|
Saturday, 16 września |
14:50
– 16:20
|
Extrapyramidal diseases
Moderator
dr hab. n. med., prof. uczelni Sławomir Budrewicz |
14:50
– 15:10
|
Gut or brain? - The mystery pathogenesis of Parkinson's disease
Wykładowca
|
15:10
– 15:30
|
Levodopa in Parkinson's disease - yesterday, today and tomorrow
Wykładowca
|
15:30
– 15:50
|
Deep brain stimulation in movement disorders - where are we now? where are we heading?
Wykładowca
prof. dr hab. n. med. Dariusz Koziorowski |
15:50
– 16:10
|
Infusion therapies in Parkinson's disease
Wykładowca
dr hab. n. med., prof. uczelni Sławomir Budrewicz |
16:10
– 16:20
|
Discussion
|
14:50
– 16:20
|
Epilepsy
|
14:50
– 15:10
|
The past, present and future in epilepsy diagnosis and treatment
|
15:10
– 15:30
|
Diagnostic pitfalls in epilepsy
Wykładowca
|
15:30
– 15:50
|
Interdisciplinary approach to diagnosis and treatment of epilepsy - the place of new technologies
Wykładowca
|
15:50
– 16:10
|
New etiologies in epilepsy - effect on treatment
|
16:10
– 16:20
|
Discussion
|
14:50
– 16:20
|
Demyelinating diseases
"Multiple sclerosis - a new era of immunomodulatory therapy" |
14:50
– 15:10
|
Historical background of the development of demyelinating diseases - from Poser to the current McDonald criteria
Wykładowca
|
15:10
– 15:30
|
Development of MS diagnostic imaging and biomarkers - from history to the present
Wykładowca
|
15:30
– 15:50
|
Development of MS therapy - from β-interferons to BTKi
Wykładowca
|
15:50
– 16:10
|
MS treatment in Poland - who do we treat and how?
Wykładowca
|
16:10
– 16:20
|
Discussion
|
Saturday, 16 września |
16:20
– 16:40
|
Coffee break
|
Saturday, 16 września |
16:40
– 18:10
|
Sponsored session
|
18:10
– 19:30
|
Neuromuscular diseases
|
18:10
– 18:30
|
Genetic neuromuscular disorders through the eyes of a neurologist: an SMA success story and more
Wykładowca
|
18:30
– 18:50
|
Genetic neuromuscular disorders through the eyes of a pediatric neurologist: an SMA success story and more
|
18:50
– 19:10
|
Acquired neuromuscular diseases
Wykładowca
dr hab. n. med. Anna Potulska-Chromik |
19:10
– 19:30
|
Discussion
|
16:40
– 18:10
|
Sponsored session
|
18:10
– 19:30
|
Gene therapy - reality or future?
Moderator
|
18:10
– 18:30
|
Gene therapy and its application in aromatic L-amino amino acid decarboxylase deficiency
|
18:30
– 18:50
|
Gene therapy in SLA - from experiment to arrested disease progression
|
18:50
– 19:10
|
Safety of gene therapy
Wykładowca
|
19:10
– 19:20
|
Discussion
|
16:40
– 18:10
|
Sponsored session
|
18:10
– 19:30
|
Hot topics in neuroimmunology
Moderator
|
18:10
– 18:30
|
The challenges of progressive multiple sclerosis
Wykładowca
|
18:30
– 18:50
|
Remyelination
Wykładowca
|
18:50
– 19:10
|
MS risk factors, role of EBV infection
Wykładowca
|
19:10
– 19:30
|
De-escalation of MS therapy, if and when?
Wykładowca
|
Saturday, 16 września |
19:30
– 19:45
|
CLOSING
|